These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26197515)

  • 1. Computational and Investigative Study of Flavonoids Active Against Typanosoma cruzi and Leishmania spp.
    Ribeiro FF; Junior FJ; da Silva MS; Scotti MT; Scotti L
    Nat Prod Commun; 2015 Jun; 10(6):917-20. PubMed ID: 26197515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico molecular docking studies of new potential 4-phthalazinyl-hydrazones on selected Trypanosoma cruzi and Leishmania enzyme targets.
    Romero AH; López SE
    J Mol Graph Model; 2017 Sep; 76():313-329. PubMed ID: 28763686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of Trypanosoma cruzi dihydroorotate dehydrogenase from Y strain.
    Pinheiro MP; Iulek J; Cristina Nonato M
    Biochem Biophys Res Commun; 2008 May; 369(3):812-7. PubMed ID: 18302934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
    Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
    J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of 9,9-dimethylxanthene tricyclics against trypanothione reductase, Trypanosoma brucei, Trypanosoma cruzi and Leishmania donovani.
    Chibale K; Visser M; Yardley V; Croft SL; Fairlamb AH
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1147-50. PubMed ID: 10866368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and characterization of a pyridine-2-thiol N-oxide gold(I) complex with potent antiproliferative effect against Trypanosoma cruzi and Leishmania sp. insight into its mechanism of action.
    Vieites M; Smircich P; Guggeri L; Marchán E; Gómez-Barrio A; Navarro M; Garat B; Gambino D
    J Inorg Biochem; 2009 Oct; 103(10):1300-6. PubMed ID: 19361864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductase.
    Persch E; Bryson S; Todoroff NK; Eberle C; Thelemann J; Dirdjaja N; Kaiser M; Weber M; Derbani H; Brun R; Schneider G; Pai EF; Krauth-Siegel RL; Diederich F
    ChemMedChem; 2014 Aug; 9(8):1880-91. PubMed ID: 24788386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico identification and evaluation of new Trypanosoma cruzi trypanothione reductase (TcTR) inhibitors obtained from natural products database of the Bahia semi-arid region (NatProDB).
    da Paixão VG; Pita SSDR
    Comput Biol Chem; 2019 Apr; 79():36-47. PubMed ID: 30710804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal-based compounds as prospective antileishmanial agents: inhibition of trypanothione reductase by selected gold complexes.
    Colotti G; Ilari A; Fiorillo A; Baiocco P; Cinellu MA; Maiore L; Scaletti F; Gabbiani C; Messori L
    ChemMedChem; 2013 Oct; 8(10):1634-7. PubMed ID: 24039168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening.
    Turcano L; Torrente E; Missineo A; Andreini M; Gramiccia M; Di Muccio T; Genovese I; Fiorillo A; Harper S; Bresciani A; Colotti G; Ilari A
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006969. PubMed ID: 30475811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs.
    Colotti G; Baiocco P; Fiorillo A; Boffi A; Poser E; Chiaro FD; Ilari A
    Future Med Chem; 2013 Oct; 5(15):1861-75. PubMed ID: 24144416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis.
    da Rosa R; de Moraes MH; Zimmermann LA; Schenkel EP; Steindel M; Bernardes LSC
    Eur J Med Chem; 2017 Mar; 128():25-35. PubMed ID: 28152426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homology modeling of T. cruzi and L. major NADH-dependent fumarate reductases: ligand docking, molecular dynamics validation, and insights on their binding modes.
    Merlino A; Vieites M; Gambino D; Coitiño EL
    J Mol Graph Model; 2014 Mar; 48():47-59. PubMed ID: 24370672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginase Flavonoid Anti-Leishmanial in Silico Inhibitors Flagged against Anti-Targets.
    Glisic S; Sencanski M; Perovic V; Stevanovic S; García-Sosa AT
    Molecules; 2016 May; 21(5):. PubMed ID: 27164067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach.
    Pandey RK; Sharma D; Bhatt TK; Sundar S; Prajapati VK
    J Biomol Struct Dyn; 2015; 33(12):2541-53. PubMed ID: 26305585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiprotozoal effect of crude extracts and flavonoids isolated from Chromolaena hirsuta (asteraceae).
    Taleb-Contini SH; Salvador MJ; Balanco JM; Albuquerque S; de Oliveira DC
    Phytother Res; 2004 Mar; 18(3):250-4. PubMed ID: 15103676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of a hydroxybibenzyl bryophyte constituent against Leishmania spp. and Trypanosoma cruzi: in silico, in vitro and in vivo activity studies.
    Roldos V; Nakayama H; Rolón M; Montero-Torres A; Trucco F; Torres S; Vega C; Marrero-Ponce Y; Heguaburu V; Yaluff G; Gómez-Barrio A; Sanabria L; Ferreira ME; Rojas de Arias A; Pandolfi E
    Eur J Med Chem; 2008 Sep; 43(9):1797-807. PubMed ID: 18192088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antileishmanial and antitrypanosomal activities of flavanones from Baccharis retusa DC. (Asteraceae).
    Grecco Sdos S; Reimão JQ; Tempone AG; Sartorelli P; Cunha RL; Romoff P; Ferreira MJ; Fávero OA; Lago JH
    Exp Parasitol; 2012 Feb; 130(2):141-5. PubMed ID: 22143090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
    Khabnadideh S; Pez D; Musso A; Brun R; Pérez LM; González-Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2005 Apr; 13(7):2637-49. PubMed ID: 15755663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development.
    Cavazzuti A; Paglietti G; Hunter WN; Gamarro F; Piras S; Loriga M; Allecca S; Corona P; McLuskey K; Tulloch L; Gibellini F; Ferrari S; Costi MP
    Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1448-53. PubMed ID: 18245389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.